Table 3. The level of investigated biomarkers in serum and CSF in the MS group.
NFs – neurofilaments in cerebrospinal fluid; GDF-15 – Growth differentiation factor 15 in serum
MS group with stationary<br>MRI findings (n=30) | MS group with progression<br>of MRI findings (n=30) | p-value | |
---|---|---|---|
cNFs | 0.20 (0.11–1.29) | 0.30 (0.27–1.42) | 0.820 |
sGDF15 | 183 (25–760) | 172 (46–460) | 0.782 |